ATE276257T1 - Pyrazinonderivate - Google Patents
PyrazinonderivateInfo
- Publication number
- ATE276257T1 ATE276257T1 AT01945654T AT01945654T ATE276257T1 AT E276257 T1 ATE276257 T1 AT E276257T1 AT 01945654 T AT01945654 T AT 01945654T AT 01945654 T AT01945654 T AT 01945654T AT E276257 T1 ATE276257 T1 AT E276257T1
- Authority
- AT
- Austria
- Prior art keywords
- same
- different
- pyrazinone derivatives
- äar1
- cdk6
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000200292 | 2000-06-30 | ||
PCT/JP2001/005545 WO2002002550A1 (fr) | 2000-06-30 | 2001-06-28 | Nouveaux derives pyrazinone |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE276257T1 true ATE276257T1 (de) | 2004-10-15 |
Family
ID=18698183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01945654T ATE276257T1 (de) | 2000-06-30 | 2001-06-28 | Pyrazinonderivate |
Country Status (8)
Country | Link |
---|---|
US (2) | US6914062B2 (de) |
EP (1) | EP1295878B1 (de) |
AT (1) | ATE276257T1 (de) |
AU (2) | AU2001267852B2 (de) |
CA (1) | CA2413002A1 (de) |
DE (1) | DE60105610T2 (de) |
ES (1) | ES2223884T3 (de) |
WO (1) | WO2002002550A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4492348B2 (ja) | 2002-10-29 | 2010-06-30 | 萬有製薬株式会社 | 新規キノキサリノン誘導体 |
CN100439341C (zh) * | 2002-12-02 | 2008-12-03 | 弗·哈夫曼-拉罗切有限公司 | 作为促肾上腺皮质激素释放因子拮抗剂的吲唑衍生物 |
US20050171182A1 (en) * | 2003-12-11 | 2005-08-04 | Roger Briesewitz | Methods and compositions for use in the treatment of mutant receptor tyrosine kinase driven cellular proliferative diseases |
DE102004023332A1 (de) * | 2004-05-12 | 2006-01-19 | Bayer Cropscience Gmbh | Chinoxalin-2-on-derivate, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung |
CN1956982A (zh) * | 2004-05-21 | 2007-05-02 | 万有制药株式会社 | 具有氨基噻唑骨架的Cdk4、6选择性抑制剂 |
AU2008248296B2 (en) | 2007-05-07 | 2011-12-01 | Amgen Inc. | Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators, process for their preparation, and their pharmaceutical use |
MX2010006457A (es) * | 2007-12-19 | 2010-07-05 | Amgen Inc | Compuestos fusionados de piridina, pirimidina y triazina como inhibidores de ciclo celular. |
EP2223460A4 (de) | 2007-12-20 | 2011-12-28 | Bce Inc | Kontaktloses etikett mit signatur und anwendungen dafür |
US8367671B2 (en) | 2008-03-21 | 2013-02-05 | Amgen Inc. | Pyrazolo[3.4-B]pyrazine compounds as p38 modulators and methods of use as anti-inflamatory agents |
US8389533B2 (en) * | 2008-04-07 | 2013-03-05 | Amgen Inc. | Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors |
WO2010036380A1 (en) | 2008-09-26 | 2010-04-01 | Intellikine, Inc. | Heterocyclic kinase inhibitors |
EP3399026A1 (de) | 2010-06-14 | 2018-11-07 | The Scripps Research Institute | Neuprogrammierung von zellen für ein neues zellschicksal |
MY161199A (en) | 2011-03-23 | 2017-04-14 | Amgen Inc | Fused tricyclic dual inhibitors of cdk 4/6 and flt3 |
SI3226905T1 (sl) * | 2014-02-27 | 2022-04-29 | Synartro Ab | Konjugati hialuronana s farmacevtskimi učinkovinami, postopki in sestavki |
TW202237585A (zh) | 2020-11-27 | 2022-10-01 | 瑞士商瑞森製藥公司 | Cdk抑制劑 |
WO2022149057A1 (en) | 2021-01-05 | 2022-07-14 | Rhizen Pharmaceuticals Ag | Cdk inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1804328A1 (de) * | 1967-10-23 | 1969-05-22 | Donau Pharmazie Gmbh | 3-substituierte Chinoxalinone und Verfahren zur Herstellung von 3-substituierten Chinoxalin-2-Onen |
CA2002864C (en) * | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
-
2001
- 2001-06-28 AU AU2001267852A patent/AU2001267852B2/en not_active Ceased
- 2001-06-28 CA CA002413002A patent/CA2413002A1/en not_active Abandoned
- 2001-06-28 AU AU6785201A patent/AU6785201A/xx active Pending
- 2001-06-28 WO PCT/JP2001/005545 patent/WO2002002550A1/ja active IP Right Grant
- 2001-06-28 EP EP01945654A patent/EP1295878B1/de not_active Expired - Lifetime
- 2001-06-28 US US10/312,500 patent/US6914062B2/en not_active Expired - Fee Related
- 2001-06-28 AT AT01945654T patent/ATE276257T1/de not_active IP Right Cessation
- 2001-06-28 DE DE60105610T patent/DE60105610T2/de not_active Expired - Lifetime
- 2001-06-28 ES ES01945654T patent/ES2223884T3/es not_active Expired - Lifetime
-
2005
- 2005-04-14 US US11/105,534 patent/US7148224B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60105610D1 (en) | 2004-10-21 |
DE60105610T2 (de) | 2005-01-27 |
EP1295878B1 (de) | 2004-09-15 |
US6914062B2 (en) | 2005-07-05 |
CA2413002A1 (en) | 2002-12-19 |
EP1295878A4 (de) | 2004-01-28 |
US20030203907A1 (en) | 2003-10-30 |
WO2002002550A1 (fr) | 2002-01-10 |
US7148224B2 (en) | 2006-12-12 |
EP1295878A1 (de) | 2003-03-26 |
AU2001267852B2 (en) | 2006-01-19 |
ES2223884T3 (es) | 2005-03-01 |
AU6785201A (en) | 2002-01-14 |
US20050176719A1 (en) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE276257T1 (de) | Pyrazinonderivate | |
BRPI0209216B8 (pt) | derivados de quinolina e de quinazolina, composições farmacêuticas compreendendo os mesmos e seus usos | |
EP2088141A3 (de) | Zur Hemmung der Autophosphorylierung von Hepazotyten-Wachstumsfaktorrezeptoren fähige Chinolin- und Chinazolinderivate und diese enthaltende pharmazeutische Zusammensetzungen | |
DE60006216D1 (de) | Chinolinderivate und chinazolinderivate | |
YU43001A (sh) | Supstituisani biciklični derivati korisni kao sredstva protiv kancera | |
EA200100755A1 (ru) | 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты | |
WO2002051819A3 (en) | Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them | |
RU2003122190A (ru) | Производные тетрагидропиридина, их получение и применение в качестве ингибиторов клеточной пролиферации | |
NZ331060A (en) | Quinoxalinediones, preparation and pharmaceutical compositions thereof | |
SE9703377D0 (sv) | New compounds | |
SE0101579D0 (sv) | New compounds | |
EA200300071A1 (ru) | Терапевтический препарат для лечения невроза страха (тревоги) или депрессии и производные пиперазина | |
HUP0104058A2 (hu) | N-diszubsztituált piperazin vagy 1,4 diszubsztituált piperidin heterociklusos származékai és ezeket tartalmazó gyógyászati készítmények | |
ATE259376T1 (de) | Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren | |
ATE402151T1 (de) | 2-(arylphenyl)amino-imidazolin-derivate | |
DE60045821D1 (de) | Derivate von aromatische heterocyclen enthaltende integraseinhibitoren | |
RU2004130284A (ru) | Антипаразитарные производные артемизинина (эндопероксиды) | |
HRP20050617A2 (en) | Imidazol derivatives having affinity for alpha 2 receptors activity | |
EA200401077A1 (ru) | 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b | |
ATE275133T1 (de) | 1,2-dihydro-2-oxochinolin-derivate | |
EA200200379A2 (ru) | Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции | |
HUP0100751A2 (hu) | Új aril-vagy heteroaril-kinolinilfoszfonsav-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
EA200301045A3 (ru) | Новые соединения имидазолина, способ их получения и содержащие их фармацевтические композиции | |
EA200900922A1 (ru) | НОВЫЕ СОЕДИНЕНИЯ ТРИАЗАБЕНЗО[α]НАФТО[2,1,8-cde]АЗУЛЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
HUP0202237A2 (hu) | Amin, módosított pszeudomicin vegyületek, azokat tartalmazó gyógyászati készítmény és alkalmazásuk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |